---
$id: https://graph.org.ai/products/commodity/51201820
$type: Product
source: UNSPSC
code: "51201820"
title: "Thymopentin"
class: "51201800"
classTitle: "Immunostimulating agents"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Thymopentin

**UNSPSC Code**: 51201820
**Class**: [Immunostimulating agents](Immunostimulating agents.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an immunostimulant with the molecular formula C30H49N9O9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O3Y80ZF13F, chemically known as l-tyrosine, n-(n-(n-(n(sup 2)-l-arginyl-l-lysyl)-l-alpha-aspartyl)-l-valyl)- but generally known as thymopentin, which bears US NIH Compound Identifier 50587. European Medicines Agency schedules Thymopentin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10993MIG. The term THYMOPENTIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). World Health Organization schedules thymopentin in its Anatomical Therapeutic Chemical (ATC) Classification. THYMOPENTIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule thymopentin under HS 29371900 and SITC 54154. As of Q4 2014, THYMOPENTIN remains the US FDA Preferred Term for this commodity. Thymopentin bears US NLM identifiers UMLS ID C0080225 and NCI Concept Code C1294. SMILES: O=C(NC(C(=O)NC(C(C)C)C(=O)NC(CC1CCC(O)CC1)C(=O)O)CC(=O)O)C(NC(=O)C(N)CCC/N=C(/N)N)CCCCN.

